These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 19010242

  • 1. Early steroid withdrawal in pediatric renal transplantation at a single center: preliminary report.
    Valenzuela M, Delucchi A, Ferrario M, Lillo AM, Guerrero JL, Rodríguez E, Cano F, Cavada G.
    Transplant Proc; 2008 Nov; 40(9):3237-40. PubMed ID: 19010242
    [Abstract] [Full Text] [Related]

  • 2. [Early steroid withdrawal in pediatric renal transplantation].
    Delucchi B A, Valenzuela A M, Ferrario B M, Lillo D AM, Guerrero G JL, Rodríguez S E, Cano Sch F, Cavada Ch G, Godoy L J, Rodríguez H J, González G G, Buckel B E, Contreras M L.
    Rev Med Chil; 2006 Nov; 134(11):1393-401. PubMed ID: 17277852
    [Abstract] [Full Text] [Related]

  • 3. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y, Tojimbara T, Iwadoh K, Koyama I, Nanmoku K, Kai K, Sannomiya A, Nakajima I, Fuchinoue S, Teraoka S.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1984-92. PubMed ID: 17161352
    [Abstract] [Full Text] [Related]

  • 4. Early steroid withdrawal in pediatric renal transplant on newer immunosuppressive drugs.
    Delucchi A, Valenzuela M, Ferrario M, Lillo AM, Guerrero JL, Rodriguez E, Cano F, Cavada G, Godoy J, Rodriguez J, Gonzalez CG, Buckel E, Contreras L.
    Pediatr Transplant; 2007 Nov 20; 11(7):743-8. PubMed ID: 17910651
    [Abstract] [Full Text] [Related]

  • 5. Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients.
    Kim SJ, Lee KW, Lee DS, Lee HH, Lee SK, Kim B, Huh WS, Oh HY, Joh JW.
    Transplant Proc; 2004 Sep 20; 36(7):2098-100. PubMed ID: 15518759
    [Abstract] [Full Text] [Related]

  • 6. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
    Montini G, Murer L, Ghio L, Pietrobon B, Ginevri F, Ferraresso M, Cardillo M, Scalamogna M, Perfumo F, Edefonti A, Zanon GF, Zacchello G.
    Transpl Int; 2005 Jan 20; 18(1):36-42. PubMed ID: 15612981
    [Abstract] [Full Text] [Related]

  • 7. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
    Höcker B, John U, Plank C, Wühl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tönshoff B.
    Transplantation; 2004 Jul 27; 78(2):228-34. PubMed ID: 15280683
    [Abstract] [Full Text] [Related]

  • 8. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
    Oberholzer J, John E, Lumpaopong A, Testa G, Sankary HN, Briars L, Kraft KA, Knight PS, Verghese P, Benedetti E.
    Pediatr Transplant; 2005 Aug 27; 9(4):456-63. PubMed ID: 16048597
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.
    Offner G, Toenshoff B, Höcker B, Krauss M, Bulla M, Cochat P, Fehrenbach H, Fischer W, Foulard M, Hoppe B, Hoyer PF, Jungraithmayr TC, Klaus G, Latta K, Leichter H, Mihatsch MJ, Misselwitz J, Montoya C, Müller-Wiefel DE, Neuhaus TJ, Pape L, Querfeld U, Plank C, Schwarke D, Wygoda S, Zimmerhackl LB.
    Transplantation; 2008 Nov 15; 86(9):1241-8. PubMed ID: 19005406
    [Abstract] [Full Text] [Related]

  • 10. Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil.
    Höcker B, Weber LT, Feneberg R, Drube J, John U, Fehrenbach H, Pohl M, Zimmering M, Fründ S, Klaus G, Wühl E, Tönshoff B.
    Transplantation; 2009 Mar 27; 87(6):934-41. PubMed ID: 19300199
    [Abstract] [Full Text] [Related]

  • 11. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 27; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 12. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.
    Attallah N, Goggins M, Nori U, Abouljoud M, Zasuwa G, Venkat KK, Parasuraman R.
    Transplant Proc; 2005 Jun 27; 37(5):2060-2. PubMed ID: 15964338
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
    Ciancio G, Burke GW, Gaynor JJ, Roth D, Sageshima J, Kupin W, Tueros L, Hanson L, Rosen A, Ruiz P, Miller J.
    Transplantation; 2008 Jul 15; 86(1):67-74. PubMed ID: 18622280
    [Abstract] [Full Text] [Related]

  • 14. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.
    Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O.
    Transplantation; 2003 Nov 15; 76(9):1331-9. PubMed ID: 14627912
    [Abstract] [Full Text] [Related]

  • 15. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ.
    Clin Transplant; 2007 Nov 15; 21(1):101-9. PubMed ID: 17302598
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.
    Liu CL, Fan ST, Lo CM, Chan SC, Ng IO, Lai CL, Wong J.
    Liver Transpl; 2004 Jun 15; 10(6):728-33. PubMed ID: 15162466
    [Abstract] [Full Text] [Related]

  • 17. Pediatric renal transplantation under tacrolimus-based immunosuppression.
    Shapiro R, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Gilboa N, Gritsch HA, Irish W, McCauley J, Fung JJ, Hakala TR, Simmons RL, Starzl TE.
    Transplantation; 1999 Jan 27; 67(2):299-303. PubMed ID: 10075598
    [Abstract] [Full Text] [Related]

  • 18. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
    Włodarczyk Z, Wałaszewski J, Perner F, Vitko S, Ostrowski M, Bachleda P, Kokot F, Klinger M, Szenohradsky P, Studenik P, Navratil P, Asztalos L, Rutkowski B, Nagy KK, Hickey D.
    Ann Transplant; 2002 Jan 27; 7(3):28-31. PubMed ID: 12465429
    [Abstract] [Full Text] [Related]

  • 19. Cyclosporine-sparing effect of basiliximab in renal transplant recipients with mycophenolate mofetil.
    Tojimbara T, Sato S, Koyama I, Nanmoku K, Sekijima M, Tonsyo M, Kai K, Kato Y, Urashima Y, Nakajima I, Fuchinoue S, Teraoka S.
    Transplant Proc; 2005 Mar 27; 37(2):895-8. PubMed ID: 15848568
    [Abstract] [Full Text] [Related]

  • 20. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant.
    Pascual J, van Hooff JP, Salmela K, Lang P, Rigotti P, Budde K.
    Transplantation; 2006 Jul 15; 82(1):55-61. PubMed ID: 16861942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.